EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome
| dc.contributor.author | Drosos, George C. | |
| dc.contributor.author | Vedder, Daisy | |
| dc.contributor.author | Houben, Eline | |
| dc.contributor.author | Boekel, Laura | |
| dc.contributor.author | Atzeni, Fabiola | |
| dc.contributor.author | Badreh, Sara | |
| dc.contributor.author | Boumpas, Dimitrios T. | |
| dc.contributor.author | Brodin, Nina | |
| dc.contributor.author | Bruce, Ian N. | |
| dc.contributor.author | González-Gay, Miguel Ángel | |
| dc.contributor.author | Jacobsen, Søren | |
| dc.contributor.author | Kerekes, György | |
| dc.contributor.author | Marchiori, Francesca | |
| dc.contributor.author | Mukhtyar, Chetan | |
| dc.contributor.author | Ramos-Casals, Manuel | |
| dc.contributor.author | Sattar, Naveed | |
| dc.contributor.author | Schreiber, Karen | |
| dc.contributor.author | Sciascia, Savino | |
| dc.contributor.author | Svenungsson, Elisabet | |
| dc.contributor.author | Szekanecz, Zoltan | |
| dc.contributor.author | Tausche, Anne-Kathrin | |
| dc.contributor.author | Tyndall, Alan | |
| dc.contributor.author | van Halm, Vokko | |
| dc.contributor.author | Voskuyl, Alexandre | |
| dc.contributor.author | Macfarlane, Gary | |
| dc.contributor.author | Ward, Michael M. | |
| dc.contributor.author | Nurmohamed, Michael T. | |
| dc.contributor.author | Tektonidou, Maria G. | |
| dc.contributor.institution | University of Aberdeen.Vice Principals | en |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2022-05-05T23:05:19Z | |
| dc.date.available | 2022-05-05T23:05:19Z | |
| dc.date.embargoedUntil | 2022-05-06 | |
| dc.date.issued | 2022-05-16 | |
| dc.description | Acknowledgements: The committee wishes to acknowledge the support of the EULAR Standing Committee on Clinical Affairs and the EULAR Secretariat. Funding: This study was funded by European Alliance of Associations for Rheumatology, EULAR. Project number: CLI112 | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 380278 | |
| dc.identifier | 211247801 | |
| dc.identifier | 165fd5b6-5140-4a58-b835-7d7918c58743 | |
| dc.identifier | 85125531096 | |
| dc.identifier.citation | Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A-K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, 'EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome', Annals of the Rheumatic Diseases, vol. 81, pp. 768-779. https://doi.org/10.1136/annrheumdis-2021-221733 | en |
| dc.identifier.doi | 10.1136/annrheumdis-2021-221733 | |
| dc.identifier.issn | 0003-4967 | |
| dc.identifier.other | ORCID: /0000-0003-2322-3314/work/114480469 | |
| dc.identifier.uri | https://hdl.handle.net/2164/18533 | |
| dc.identifier.vol | 81 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Annals of the Rheumatic Diseases | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Recommendations | en |
| dc.subject | cardiovascular disease | en |
| dc.subject | rheumatic and musculoskeletal disease | en |
| dc.subject | traditional cardiovascular risk factors | en |
| dc.subject | disease-related risk factors | en |
| dc.subject | R Medicine | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Drosos_etal_EULAR_recommendations_for_AAM.pdf
- Size:
- 371.37 KB
- Format:
- Adobe Portable Document Format
